Stącel Tomasz, Urlik Maciej, Antończyk Remigiusz, Latos Magdalena, Wiklińska Agnieszka, Przybyłowski Piotr, Zembala Marian, Ochman Marek, Nęcki Mirosław
Silesian Center for Heart Diseases, Zabrze, Poland.
Silesian Center for Heart Diseases, Zabrze, Poland; Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, Medical University of Silesia, Katowice, Poland.
Transplant Proc. 2020 Sep;52(7):2110-2112. doi: 10.1016/j.transproceed.2020.02.114. Epub 2020 Mar 31.
Lung transplantation remains the only viable option for patients with end-stage lung diseases. However, due to an insufficient number of lung donors, many potential candidates die without undergoing the procedure. In the cases of some patients, bridges to transplantation can be implemented. One such method is extracorporeal membrane oxygenation (ECMO), which, depending on the type, has the ability to replace patients' circulatory and respiratory function.
This case study describes 4 cases of patients, who were successfully bridged to lung transplantation. The first patient developed respiratory failure as a result of acute pulmonary embolisms. His respiratory function was insufficient and he had ECMO implanted for 84 days until he was transplanted. Another patient presented respiratory failure due to massive bleeding, which occurred during transbronchial lung biopsy. Such event led to extensive exacerbation, which resulted in using ECMO as a bridge to recovery at first, but later a bridge to lung transplantation. The patient became a lung graft recipient after 14 days on ECMO. The third patient was a woman who developed severe respiratory failure during the course of the progression of her underlying disease. She was treated with ECMO for 14 days as well, and she also underwent lung transplantation. The fourth patient was qualified for retransplantation. She was bridged to retransplantation via veno-venous ECMO.
ECMO can be used a bridge to lung transplantation for suitable patients even for a long period of time, given that it is maintained in accordance with the guidelines.
肺移植仍然是终末期肺病患者唯一可行的选择。然而,由于肺供体数量不足,许多潜在的候选者在未接受该手术的情况下死亡。对于一些患者,可以采用移植过渡措施。其中一种方法是体外膜肺氧合(ECMO),根据类型不同,它有能力替代患者的循环和呼吸功能。
本病例研究描述了4例成功过渡到肺移植的患者。首例患者因急性肺栓塞出现呼吸衰竭。其呼吸功能不足,植入ECMO 84天后接受移植。另一例患者因经支气管肺活检时发生大出血出现呼吸衰竭。该事件导致病情广泛加重,起初使用ECMO作为恢复过渡手段,但后来作为肺移植过渡手段。该患者在使用ECMO 14天后成为肺移植受者。第三例患者是一名女性,在基础疾病进展过程中出现严重呼吸衰竭。她也接受了14天的ECMO治疗,并接受了肺移植。第四例患者符合再次移植条件。她通过静脉-静脉ECMO过渡到再次移植。
对于合适的患者,只要按照指南维持,ECMO可作为肺移植的过渡手段,甚至可使用较长时间。